UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Parsortix™ Cell Separation System—A versatile liquid biopsy platform

Cytometry. Part A, 2018-12, Vol.93 (12), p.1234-1239

2018

Volltextzugriff (PDF)

Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women

American journal of obstetrics and gynecology, 2011-10, Vol.205 (4), p.358.e1-358.e6

2011

Volltextzugriff (PDF)

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass

Obstetrics and gynecology (New York. 1953), 2011-08, Vol.118 (2 Pt 1), p.280-288

2011

Volltextzugriff (PDF)

Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival

British journal of cancer, 2020-03, Vol.122 (6), p.801-811

2020

Volltextzugriff (PDF)

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2008-10, Vol.14 (19), p.6302-6309

2008

Volltextzugriff (PDF)

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3213-3221

2008

Volltextzugriff (PDF)

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

American journal of obstetrics and gynecology, 2010-09, Vol.203 (3), p.228.e1-228.e6

2010

Volltextzugriff (PDF)

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer

Clinical cancer research, 2015-06, Vol.21 (11), p.2487-2498

2015

Volltextzugriff (PDF)

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Clinical cancer research, 2004-10, Vol.10 (20), p.6897-6904

2004

Volltextzugriff (PDF)

Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

Clinical cancer research, 2006-11, Vol.12 (21), p.6403-6409

2006

Volltextzugriff (PDF)

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

The New England journal of medicine, 2004-08, Vol.351 (8), p.781-791

2004

Volltextzugriff (PDF)

Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

Clinical cancer research, 2006-07, Vol.12 (14), p.4218-4224

2006

Volltextzugriff (PDF)

HE4 (WFDC2) gene overexpression promotes ovarian tumor growth

Scientific reports, 2014-01, Vol.4 (1), p.3574-3574, Article 3574

2014

Volltextzugriff (PDF)

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

Journal of clinical oncology, 2005-03, Vol.23 (7), p.1420-1430

2005

Volltextzugriff (PDF)

Identification of circulating tumor cells captured by the FDA-cleared Parsortix ® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations

Journal of experimental & clinical cancer research, 2024-08, Vol.43 (1), p.240-20

2024

Volltextzugriff (PDF)

Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3303-3311

2009

Volltextzugriff (PDF)

Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice

Clinical colorectal cancer, 2016-12, Vol.15 (4), p.381-388

2016

Volltextzugriff (PDF)

Global gene expression profiling of circulating tumor cells

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (12), p.4993-4997

2005

Volltextzugriff (PDF)

Statistical considerations for enumeration of circulating tumor cells

Cytometry. Part A, 2007-03, Vol.71A (3), p.154-162

2007

Volltextzugriff (PDF)

Extended Peripheral Zone Biopsy Schemes Increase Cancer Detection Rates and Minimize Variance in Prostate Specific Antigen and Age Related Cancer Rates: Results of a Community Multi-Practice Study

The Journal of urology, 2003, Vol.169 (1), p.125-129

2003

Volltextzugriff (PDF)

Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass

Gynecologic oncology, 2015-11, Vol.139 (2), p.248-252

2015

Volltextzugriff (PDF)

MESOMARK™ : A potential test for malignant pleural mesothelioma

Clinical chemistry (Baltimore, Md.), 2007-04, Vol.53 (4), p.666-672

2007

Volltextzugriff (PDF)

Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy

The Prostate, 2010-09, Vol.70 (12), p.1333-1339

2010

Volltextzugriff (PDF)

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Gynecologic oncology, 2009-01, Vol.112 (1), p.40-46

2009

Volltextzugriff (PDF)

Natural history of disease progression in patients who fail to achieve an undetectable prostate‐specific antigen level after undergoing radical prostatectomy

Cancer, 2004-12, Vol.101 (11), p.2549-2556

2004

Volltextzugriff (PDF)

1 – 25 von 2.187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.980)
Mit Volltextzugriff
(1.822)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.526)
Life Sciences & Biomedicine
(1.219)
Humans
(895)
Male
(530)
Female
(502)
Biological And Medical Sciences
(421)
Medical Sciences
(362)
Middle Aged
(324)
Animals
(305)
Adult
(271)
Cardiovascular System & Cardiology
(263)
Aged
(255)
Cardiac & Cardiovascular Systems
(247)
Surgery
(238)
Physical Sciences
(233)
Treatment Outcome
(136)
Respiratory System
(132)
Adolescent
(130)
Child
(121)
Aged, 80 And Over
(119)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

The Parsortix™ Cell Separation System—A versatile liquid biopsy platform

Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass

Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

HE4 (WFDC2) gene overexpression promotes ovarian tumor growth

Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

Identification of circulating tumor cells captured by the FDA-cleared Parsortix ® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations

Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer

Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice

Global gene expression profiling of circulating tumor cells

Statistical considerations for enumeration of circulating tumor cells

Extended Peripheral Zone Biopsy Schemes Increase Cancer Detection Rates and Minimize Variance in Prostate Specific Antigen and Age Related Cancer Rates: Results of a Community Multi-Practice Study

Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass

MESOMARK™ : A potential test for malignant pleural mesothelioma

Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Natural history of disease progression in patients who fail to achieve an undetectable prostate‐specific antigen level after undergoing radical prostatectomy

Suchergebnisse filtern